Menu Close

Liver Institute Northwest

Kris V. Kowdley MD

Liver Institute Northwest is open for in-person and telemedicine consultations.

We see patients in our Seattle office for clinical consultations as well as clinical research trials. Fully committed to the health and safety of our patients, staff, and greater community, we are closely monitoring the COVID-19 situation and have implemented extensive precautions and procedures to help ensure everyone’s safety. Your health and safety are our top priority, and we will continue to update you as we receive more information.


Director, Liver Institute Northwest

Professor of Medicine

Elson S. Floyd College of Medicine

Washington State University


New Liver News

October is

Liver Awareness Month!


We are pleased to announce the following;

Pacific Northwest GI and Liver Update, October 4-5, 2024

Hyatt at Olive 8

Seattle, WA

Course Directors:


V. Raman Muthusamy, MD, MAS

Michael Chiorean, MD


Kris V. Kowdley MD is recognized on 2021 Highly Cited Researchers list at WSU

See News.WSU.EDU for more.



Our Mission

The mission of the Liver Institute Northwest is to improve the liver health of people in the Pacific Northwest. We bring state-of-the-art treatment and cutting-edge clinical trials offering new therapies for patients with liver disease. Our goal is to increase access for patients to clinical trials and clinical care, advocacy on behalf of patients with liver disease, and evidence-based education on best practices for patients and providers.

Clinical Consultations

We’re happy to offer clinical consultations for patients with any liver-related issue. If you are interested in scheduling an appointment with Dr. Kowdley, please Contact Us.


We offer Fibroscan assessment of liver health at our clinic. If you are interested in being seen at our clinic for a Fibroscan evaluation, please Contact Us.


We are currently focused on clinical trials in fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hereditary hemochromatosis and chronic hepatitis B and other liver diseases.  If you are interested in participating in a clinical trial, please See Our Research Page.